AR110347A1 - ANTI-KREMEN2 ANTIBODIES AND METHODS FOR USE - Google Patents

ANTI-KREMEN2 ANTIBODIES AND METHODS FOR USE

Info

Publication number
AR110347A1
AR110347A1 ARP170103465A ARP170103465A AR110347A1 AR 110347 A1 AR110347 A1 AR 110347A1 AR P170103465 A ARP170103465 A AR P170103465A AR P170103465 A ARP170103465 A AR P170103465A AR 110347 A1 AR110347 A1 AR 110347A1
Authority
AR
Argentina
Prior art keywords
kremen2
antibodies
methods
antibody
drug
Prior art date
Application number
ARP170103465A
Other languages
Spanish (es)
Inventor
David Liu
Sarah Fong
Samuel A Williams
Original Assignee
Abbvie Stemcentrx Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Stemcentrx Llc filed Critical Abbvie Stemcentrx Llc
Publication of AR110347A1 publication Critical patent/AR110347A1/en

Links

Abstract

Se proveen anticuerpos y conjugados de fármaco y anticuerpo anti-KREMEN2, y métodos para usar dichos anticuerpos y conjugados de fármaco y anticuerpo anti-KREMEN2 para el tratamiento del cáncer. ADN, vector y célula huésped.Antibodies and anti-KREMEN2 antibody and drug conjugates are provided, and methods for using said antibodies and anti-KREMEN2 drug and antibody conjugates for cancer treatment. DNA, vector and host cell.

ARP170103465A 2016-12-09 2017-12-12 ANTI-KREMEN2 ANTIBODIES AND METHODS FOR USE AR110347A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662432050P 2016-12-09 2016-12-09

Publications (1)

Publication Number Publication Date
AR110347A1 true AR110347A1 (en) 2019-03-20

Family

ID=65895699

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170103465A AR110347A1 (en) 2016-12-09 2017-12-12 ANTI-KREMEN2 ANTIBODIES AND METHODS FOR USE

Country Status (1)

Country Link
AR (1) AR110347A1 (en)

Similar Documents

Publication Publication Date Title
CY1122653T1 (en) ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF
PH12018500380A1 (en) Anti-dll3 antibody drug conjugates and methods of use
UY37278A (en) ANTI-B7-H3 ANTIBODIES AND DRUG AND ANTIBODY CONJUGATES
CL2018001000A1 (en) Antibodies and antibody conjugates and anti-egfr drug.
CL2016002667A1 (en) Novel anti-rnf43 antibodies and methods for use
BR112019012343A2 (en) il-11ra antibodies
CO2017001023A2 (en) Antibody-Carrier Compositions and Methods for Making and Using Them
BR112018007296A2 (en) antibody conjugates comprising toll-like receptor agonist
AR101845A1 (en) ANTI-HER2 AND IMMUNOCUSED ANTIBODIES
CO2017003005A2 (en) Anti-mfi2 antibodies
MX2018006249A (en) Novel anti-emr2 antibodies and methods of use.
MX2018007817A (en) Novel anti-mmp16 antibodies and methods of use.
EA201792312A1 (en) CONSTRUCTIONS BASED ON KALIHEAMICIN AND METHODS OF THEIR APPLICATION
ECSP20082970A (en) ANTI-SEZ6 DRUG AND ANTIBODY CONJUGATES AND METHODS OF USE
MX2018013484A (en) Novel anti-tnfrsf21 antibodies and methods of use.
MX2018007818A (en) Novel anti-upk1b antibodies and methods of use.
AR110347A1 (en) ANTI-KREMEN2 ANTIBODIES AND METHODS FOR USE
AR101757A1 (en) ANTI-MFI2 ANTIBODIES AND METHODS OF USE
EA201990505A1 (en) ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND THEIR COMBINATIONS
EA202092450A2 (en) COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR TUMOR TREATMENT

Legal Events

Date Code Title Description
FB Suspension of granting procedure